US9463189B2 | 合法醫療器材資訊網
Disclosedhereinarenewmethodsoftreatmentofnon-alcoholicfattyliver...108090000029PeroxisomeProliferator-ActivatedReceptorsProteins0.000title...102100010966Alanineaminotransferase1Humangenes0.000description13...239000003153chem
This application is a continuation of U.S. application Ser. No. 12/017,912, filed Jan. 2, 2008, which claims the benefit of priority of U.S. provisional application No. 60/886,287, filed Jan. 23, 2007, the disclosures of which are hereby incorporated by reference as if written herein in their entireties.
Disclosed herein are new methods of treatment of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and other fibrotic diseases of the liver in a subject by modulating PPARδ with sulfonyl-substituted bicyclic compounds and compositions as pharmaceuticals.
Nonalcoholic steatohepatitis or NASH is a liver disease which resembles alcoholic hepatitis on liver biopsy, but occurs in patients who have no known history of alcohol abuse. First described by Luwig et al., (Ludwig, J. Mayo Clin Proc. (1980) 55:434-438), NASH is characterized by hyperinsulinemia, insulin res...
Establishment Registration & Device Listing | 合法醫療器材資訊網
Establishment Registration & Device Listing | 合法醫療器材資訊網
FISHER DIAGNOSTICS | 合法醫療器材資訊網
Hyperhomocysteinemia does not Perturb Protein C and ... | 合法醫療器材資訊網
Hyperhomocysteinemia Relates to the Subtype of ... | 合法醫療器材資訊網
Safety Assessment of Bacteroides uniformis CECT 7771 ... | 合法醫療器材資訊網
US9463189B2 | 合法醫療器材資訊網
【"費雪" 丙胺酸轉胺酶(活化)檢驗試劑組(未滅菌)】許可證字號:衛部醫器輸壹字第018759號
器材品名:"費雪"丙胺酸轉胺酶(活化)檢驗試劑組(未滅菌)許可證字號:衛部醫器輸壹字第018759號註銷狀態:註銷日期:註銷理由:有...